Invasive group A streptococcal infections, clinical manifestations and their predictors, Montreal, 1995-2001

Maria-Graciela Hollm-Delgado1, Robert Allard, Pierre A Pilon

  • 1Direction de Santé Publique, Montréal, Québec, Canada.

Insights

Invasive group A streptococcal infections (IGASI) showed a rising risk of pneumonia but a falling risk of soft-tissue infections between 1995-2001. Host and environmental factors, not specific M1/M3 serotypes, likely influenced these clinical changes.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Microbiology

Background:

  • Invasive group A streptococcal infections (IGASI) pose a significant public health concern.
  • Understanding temporal trends and clinical manifestations of IGASI is crucial for effective public health strategies.
  • Previous research has not fully elucidated the factors driving changes in IGASI clinical presentations.

Purpose of the Study:

  • To analyze the incidence and clinical manifestations of IGASI in Montreal from 1995 to 2001.
  • To investigate temporal trends in the occurrence of pneumonia and soft-tissue infections associated with IGASI.
  • To explore the role of specific serotypes and host/environmental factors in IGASI clinical outcomes.

Main Methods:

  • Passive population-based surveillance was employed to identify IGASI cases.
  • Data on clinical manifestations, serotypes, patient demographics, and underlying conditions were collected.
  • Statistical analyses, including odds ratios and confidence intervals, were used to assess temporal trends and associations.

Main Results:

  • A total of 306 IGASI cases were identified, with an average annual incidence of 2.4 per 100,000 persons and a 14% mortality rate.
  • The incidence of pneumonia among IGASI cases significantly increased from 0.06 to 0.50 per 100,000 between 1995 and 2000 (OR=1.21).
  • Conversely, the odds of soft-tissue infections decreased (OR=0.86), while serotypes M1 and M3, though common, were not linked to specific manifestations.

Conclusions:

  • Temporal shifts in IGASI clinical patterns, specifically an increase in pneumonia and decrease in soft-tissue infections, were observed.
  • The development of specific clinical manifestations appears to be influenced more by host and environmental factors than by the infecting serotype.
  • Further research is needed to identify the specific host and environmental factors contributing to these observed temporal changes in IGASI.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...